07 Aug 2013, BioSpectrum Bureau , BioSpectrum
Singapore: Daiichi Sankyo is expanding its use of US-based Medidata Solutions' cloud-based platform to support clinical trials conducted by its division in China. Daiichi Sankyo will bring Medidata's applications for electronic data capture (EDC) and clinical data management (CDM) and randomization and trial supply management (RTSM) to its expanding clinical work in China.
By adopting Medidata's data capture, management and reporting solution in conjunction with its agile randomization and trial supply management solution, Daiichi Sankyo will have access to a single cloud-based platform that provides a unified environment in which site staff will conduct patient randomization, supply dispensing and clinical data capture, as well as enabling collaboration and insightful metrics visibility for the whole research team.
Medidata Services partner Tigermed, a leading contract research organization (CRO), was involved in the selection and implementation of the Medidata platform for the China-based work.
"Medidata and Daiichi Sankyo have a long and fruitful relationship as collaborators, and we are delighted they have asked us to provide the efficient, effective and modern infrastructure needed for their clinical development programs in China," said Mr Glen de Vries, president, Medidata Solutions.